IMPROVING THE QUALITY OF REVASCULARISATION IN HIGH-RISK PATIENT SUBSETS (I)

Dr Asad Shabbir is an Interventional Cardiology Registrar at the John Radcliffe Hospital, Oxford and is also an Honorary Clinical Research Fellow at the William Harvey Research Institute, Queen Mary University of London, where he is completing his PhD. He completed his interventional cardiology fellowship at Hospital Clinico San Carlos, Madrid, Spain. Asad has an interest in complex coronary interventions, CTO PCI, and translational basic science.

Dr Dejan Milasinovic is an interventional cardiologist at the Department of Cardiology, Clinical Center of Serbia. He is also an Assistant Professor at Faculty of Medicine, University of Belgrade. His main research interests focus in the fields of the invasive treatment of acute coronary syndromes and complex coronary interventions, with an emphasis on bifurcation PCI and intracoronary guidance. In 2016, Dr Milasinovic received the EuroPCR 2016 Best Abstract award, for a work on the timing of invasive coronary intervention in patients with non-ST-segment elevation myocardial infarction. He is a member of European Association of Percutaneous Cardiovascular Interventions (EAPCI) and has served as program committee member of the annual EuroPCR conference. Dr Milasinovic also serves on the editorial boards of EuroIntervention (editorial consultant) and PCRonline and is the Chair of the EAPCI Young committee.

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >700 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 100) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.

Dr Justin Davies is a board member of Monaco Cardio at the Princess Grace Hospital, Monaco, and an interventional cardiologist with over 15 years of experience as a leading educator in the field. His clinical and academic career was established at Hammersmith Hospital, Imperial College London, where he built an international reputation for innovation in cardiovascular medicine. Over the course of his career, he has successfully mentored 15 PhD students, published more than 500 peer-reviewed papers — including landmark studies in the New England Journal of Medicine and The Lancet — and holds 20 patents in cardiovascular medicine and technology. He was the co-principal investigator of the DEFINE-FLAIR study, which helped establish iFR (Instantaneous Wave-Free Ratio), a diagnostic technique he invented, as a globally adopted standard in coronary physiology. His work reflects a unique blend of scientific innovation, academic leadership, and clinical excellence. In addition to his research and academic commitments, Justin is CEO of Cerebria AI, where he leads the development of next-generation AI-powered cardiovascular imaging and physiology tools. Under his leadership, Cerebria AI is advancing cutting-edge solutions that integrate artificial intelligence with frontline cardiology to enhance clinical decision-making and patient outcomes. Combining deep clinical expertise with entrepreneurial vision, he continues to guide international ventures through funding, regulatory pathways, and commercialization, while remaining committed to transforming cardiovascular care on a global scale.

Dr Pablo Salinas is an interventional cardiologist at Hospital Clínico San Carlos in Madrid, Spain. He earned his medical degree from the Universidad Complutense de Madrid and completed his training in cardiology and interventional cardiology at Hospital La Paz in Madrid. He later obtained his PhD from the Universidad Autónoma de Madrid. With over a decade of experience, Dr. Salinas is a highly skilled operator in complex percutaneous coronary interventions (CHIP and CTO). His expertise also includes patent foramen ovale closure, left atrial appendage closure, and pulmonary embolism intervention. Throughout his research career, Dr. Salinas has authored more than 100 indexed publications and is actively involved in multicenter clinical trials in the fields of PCI, stroke prevention interventions, and pulmonary embolism treatment. His clinical approach emphasizes the refinement of interventional techniques to achieve optimal outcomes while prioritizing the patient’s perspective and experience. In addition to his clinical work, Dr. Salinas is actively engaged in education and training at a teaching university hospital with an international interventional fellowship program. He frequently participates in educational events and live case demonstrations. Outside of his professional commitments, he enjoys photography, tennis, and hiking mountain trails.

Ranil de Silva is Senior Lecturer in Clinical Cardiology at the National Heart and Lung Institute, Imperial College London and Consultant Interventional Cardiologist at the Royal Brompton Hospital, London, UK. He obtained his medical degree from King’s College London and undertook his PhD in PET imaging at the MRC Cyclotron Unit under Attilio Maseri. His post-doctoral research was at the National Institutes of Health, USA working on MRI guided endovascular intervention and cardiovascular regenerative medicine. His research focuses on imaging to guide the diagnosis, risk stratification and evaluation of novel therapies for patients with acute and chronic coronary syndromes. He leads translational interdisciplinary research programs on coronary atherosclerotic plaque biomechanics evaluated by fluid-structure interaction modelling, post-myocardial infarction left ventricular remodelling using diffusion tensor cardiovascular magnetic resonance, and coronary sinus reducer for treating coronary microvascular dysfunction. He has published more than 100 peer reviewed articles, including Circulation, European Heart Journal, JACC, Nature journals, Lancet and NEJM. He has an h-index 43. He leads the Specialist Angina Service at the Royal Brompton Hospital, which is a nationally recognised service for patients with refractory angina. He is an interventional cardiologist undertaking complex interventional procedures, coronary sinus reduction, LV support and the full range of intracoronary imaging and physiology techniques. He also has an interest in resistant hypertension and has experience in renal denervation.

Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.

Dr Vasileios Panoulas is a Consultant Interventional Cardiologist at the Royal Brompton and Harefield hospitals, part of the Guys and St Thomas NHS Foundation Trust and Honorary Senior Clinical Lecturer at Imperial College London. He has clinical expertise that encompasses both general and interventional cardiology. He is a high volume PCI and TAVI (trans catheter aortic valve implantation) operator with interest in complex high risk PCI and use of mechanical circulatory support (MCS) in patients with cardiogenic shock. Dr Panoulas' research interests involve clinical outcomes with new generation TAVI devices, use of MCS in patients presenting with cardiogenic shock, management of acute coronary syndromes (ACS) and hypertension. Other interests include speckle tracking and hand-held echocardiography and cardiovascular disease in patients with rheumatoid arthritis.